For decades, surgeons operating on the pancreas and stomach have sought a chemical ally to seal the fragile edges their scalpels leave behind — a wound that biology, not technique, so often refuses to close cleanly. A systematic review of nearly 1,800 patients, published in a respected surgical journal, has now confirmed what some quietly suspected: cyanoacrylate adhesive glue, despite its mechanical promise, offers no measurable protection against fistula or post-operative bleeding in pancreatic resection or sleeve gastrectomy. The search for a shortcut to healing has, once again, returned su
Afya | Home
· May 20, 2026
· health
· 3 min read
High
Sourcing: Verified
Cyanoacrylate Glue Fails to Reduce Post-Surgical Fistula Risk
Pancreatic fistula and post-operative bleeding complications significantly increase patient morbidity and mortality following pancreatic resection and sleeve gastrectomy procedures.
◉
Health & Medicine
2746 related articles
Ozempic and GLP-1 drugs: how the weight-loss revolution works and what…
O GLOBO · 99% match
Eli Lilly's retatrutida shows 28% weight loss in trials, rivaling bari…
Poder360 · 90% match
GLP-1 drugs like Ozempic expand beyond weight loss into Alzheimer's, h…
Folha de S.Paulo · 90% match
Retatrutida achieves 30% weight loss in landmark obesity study
Veja Saúde · 90% match
Anvisa aprova remdesivir contra covid-19 e registra vacina de Oxford
Jornal de Brasília · 90% match
Related Coverage
G1 · Aug 20
Pai agradece médicos após morte de gêmeas unidas pela cabeça: 'mais vitórias que derrotas'
Pai das gêmeas unidas pela cabeça que morreram em cirurgia de separação agradece empenho de mais de 50 profissionais do …
Folha de S.Paulo · Aug 20 Selton Mello se emociona ao receber Kikito de Cristal em GramadoSelton Mello recebeu o Kikito de Cristal no Festival de Gramado e se emocionou ao lembrar que era a primeira vez receben…
G1 · Aug 20 CEMEI Amiguinhos da Vila inaugura prédio moderno com capacidade para 320 alunosInaugurado novo prédio do CEMEI Amiguinhos da Vila em Montes Claros, com capacidade para 320 alunos, oito salas de aula,…
Folha de S.Paulo · Aug 20 Hepatites D e E circulam no Brasil e preocupam especialistasRevisão de 200 estudos com dados de 14,5 milhões de pessoas revela que hepatites D e E circulam no Brasil com prevalênci…
Bias & Framing
⚖
Medical research article presenting systematic review findings with neutral, evidence-based framing; minimal bias detected in presentation of surgical outcomes data.
Bias Direction
center
Confidence
HIGH
Evidence-based medical reporting using systematic review methodology; presents negative findings about cyanoacrylate glue efficacy in objective, clinical language without sensationalism or advocacy.
Manufacturer or industry perspective on the findings
Patient experience or quality-of-life outcomes
Cost-effectiveness analysis compared to alternative interventions
Perspectives from surgeons who actively use cyanoacrylate adhesives
Discussion of why previous clinical expectations existed
Geopolitical Impact
🌎
Medical research on surgical adhesive effectiveness has no geopolitical implications; this is a clinical study on post-operative complication management.
Escalation Risk
N/A
Confidence
HIGH
Economic Lens
📈
Systematic review of 1,800 patients shows cyanoacrylate adhesive fails to reduce post-surgical fistula and bleeding complications in pancreatic and sleeve gastrectomy procedures, negating previous clinical expectations.
Market Signal
bearish
Confidence
HIGH
Healthcare/Medical Devices
Surgical Supplies Manufacturing
Hospital Services
Pharmaceutical/Biotech
Patients undergoing pancreatic and bariatric surgeries face continued high complication rates (15-16% fistula/bleeding in pancreatic cases; 4-4.7% in sleeve gastrectomy). Healthcare costs may remain elevated due to prolonged recovery and treatment of complications. Patients cannot benefit from this adhesive technology as a risk mitigation strategy.
Regulatory bodies may need to reassess approval status and clinical recommendations for cyanoacrylate adhesives in these surgical applications. Healthcare systems should redirect resources toward alternative fistula prevention strategies. Medical device manufacturers may face pressure to develop more effective solutions or face reimbursement restrictions.